Overview

Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm

Status:
Completed
Trial end date:
2019-10-09
Target enrollment:
Participant gender:
Summary
The rational of this study is to provide evidence on the safety and efficacy of a new chewable tablet of mebendazole compared to the standard tablet in preschool- and school-aged children infected with hookworm.
Phase:
Phase 2
Details
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborator:
Public Health Laboratory Ivo de Carneri
Treatments:
DMP 777
Mebendazole
Piperazine
Piperazine citrate